助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   transurethral surgery 在 肿瘤学 分类中 的翻译结果: 查询用时:0.191秒
图标索引 在分类学科中查询
所有学科
肿瘤学
泌尿科学
更多类别查询

图标索引 历史查询
 

transurethral surgery
相关语句
  “transurethral surgery”译为未确定词的双语例句
    Transurethral surgery for bladder transitional cell carcinoma with BPH
    同期行经尿道电切术治疗膀胱癌并前列腺增生的临床观察
短句来源
    Analysis of the Transurethral Surgery for Bladder Transitional Cell Carcinoma with Benign Prostatic Hyperplasia
    膀胱癌并前列腺增生经尿道同期电切术的临床观察
短句来源
    Transurethral surgery for bladder transitional cell carcinoma with benign prostatic hyperplasia (BPH)
    同期行经尿道膀胱癌电切术并前列腺增生汽化切割术的临床观察
短句来源
    BACKGROUND & OBJECTIVE: Superficial transitional cell carcinoma (TCC) of urinary bladder tends to recur after transurethral surgery. This study was designed to evaluate the effect of interferon alpha(IFN α)and pirarubicin(THP)on decreasing postoperative recurrence of superficial bladder cancer.
    背景与目的浅表性膀胱移行细胞癌术后易复发,本研究旨在探讨α-干扰素(interferon-alpha,IFN-α)联合吡柔比星灌注在降低浅表性膀胱癌术后复发方面的价值。
短句来源
查询“transurethral surgery”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  transurethral surgery
FOM and CTM response rates were 92.9% and 94.9%, respectively, in transurethral surgery patients, and 87.2% and 85.4% in open-surgery patients.
      
The area density of smooth muscle, fibrous tissue, glandular epithelium, and glandular lumen in BPH adenoma resected by transurethral surgery was estimated using morphometric analysis.
      
The role of the anterior urethral culture and its relationship to post-operative urine infection in patients undergoing transurethral surgery was studied in 43 consecutive patients.
      
Editorial: Antibacterial therapy and prophylaxis in transurethral surgery
      
In man, absorption was highest after transurethral surgery.
      
更多          


BACKGROUND & OBJECTIVE: Superficial transitional cell carcinoma (TCC) of urinary bladder tends to recur after transurethral surgery. This study was designed to evaluate the effect of interferon alpha(IFN α)and pirarubicin(THP)on decreasing postoperative recurrence of superficial bladder cancer. METHODS: Recombinant IFN α and THP has been used in clinical study. One week After operation, 68 patients were prospectively enrolled and divided into two groups randomly: IFN α plus THP group and THP group. The...

BACKGROUND & OBJECTIVE: Superficial transitional cell carcinoma (TCC) of urinary bladder tends to recur after transurethral surgery. This study was designed to evaluate the effect of interferon alpha(IFN α)and pirarubicin(THP)on decreasing postoperative recurrence of superficial bladder cancer. METHODS: Recombinant IFN α and THP has been used in clinical study. One week After operation, 68 patients were prospectively enrolled and divided into two groups randomly: IFN α plus THP group and THP group. The protocols of chemoimmunoprophylaxis include 8 weekly and 10 monthly instillation of 3×107 IU IFN α plus 40 mg THP in 40 ml 5% glucose via catheter. RESULTS: The follow up period ranged from 6 to 32 months (median 18.2 months). The cytoscopy and cytology with cold cup biopsies had been carried out every 3 months for 2 years. Recurrence after instillation of IFN α combining THP was observed in only 4 cases (12.1%), bladder irritation was found in 4 cases, fatigue in 3 cases, and rash in 1 case as well. Among the 35 cases in THP group, recurrence was found in 8 cases (22.8%), bladder irritation in 5 cases, fatigue in 3 cases. IFN α plus THP yielded better effect than THP alone (P< 0.05),especially in grade 3 and stage PT1 bladder cancer. CONCLUSIONS: IFN α working in coordination with THP would be an effective remedy to prevent the recurrence of bladder cancer. The intravesical IFN α plus THP appears to be more effective against recurrence than THP alone. Further study is needed for side effect and popularization in such way.

背景与目的浅表性膀胱移行细胞癌术后易复发,本研究旨在探讨α-干扰素(interferon-alpha,IFN-α)联合吡柔比星灌注在降低浅表性膀胱癌术后复发方面的价值。方法应用重组人干扰素和吡柔比星(pirarubicin,THP)进行临床前瞻性试验研究。68例膀胱癌患者术后一周随机数字法分为两组(1)IFN-α+THP组33例,IFN-α3000万IU+THP40mg+5%GS40ml膀胱灌注;(2)THP组35例,THP40mg+5%GS40ml膀胱灌注。每周1次,连续8次,以后每月1次,共10次,12个月为一个疗程。结果随访期为6~32个月(中位随访期18.5个月),每3个月行膀胱镜检和组织活检一次。IFN-α+THP组33例患者中复发4例(12.1%),有4例出现膀胱刺激症状,3例有疲倦症状,1例出现皮疹。THP组复发8例(22.8%),有5例出现膀胱刺激症状,疲倦者3例,两组的不良反应发生率无显著性差异(P>0.05)。IFN-α+THP组比单用THP组有更好的疗效(P<0.05),尤其在预防G2、PT1膀胱肿瘤术后复发的效果优于单用THP组。结论IFN-α加THP灌注化疗对预防膀胱癌术后复发的疗效...

背景与目的浅表性膀胱移行细胞癌术后易复发,本研究旨在探讨α-干扰素(interferon-alpha,IFN-α)联合吡柔比星灌注在降低浅表性膀胱癌术后复发方面的价值。方法应用重组人干扰素和吡柔比星(pirarubicin,THP)进行临床前瞻性试验研究。68例膀胱癌患者术后一周随机数字法分为两组(1)IFN-α+THP组33例,IFN-α3000万IU+THP40mg+5%GS40ml膀胱灌注;(2)THP组35例,THP40mg+5%GS40ml膀胱灌注。每周1次,连续8次,以后每月1次,共10次,12个月为一个疗程。结果随访期为6~32个月(中位随访期18.5个月),每3个月行膀胱镜检和组织活检一次。IFN-α+THP组33例患者中复发4例(12.1%),有4例出现膀胱刺激症状,3例有疲倦症状,1例出现皮疹。THP组复发8例(22.8%),有5例出现膀胱刺激症状,疲倦者3例,两组的不良反应发生率无显著性差异(P>0.05)。IFN-α+THP组比单用THP组有更好的疗效(P<0.05),尤其在预防G2、PT1膀胱肿瘤术后复发的效果优于单用THP组。结论IFN-α加THP灌注化疗对预防膀胱癌术后复发的疗效可能优于单用THP,但是其副作用情况以及是否适宜广泛使用还需作进一步的研究。

 
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关transurethral surgery的内容
在知识搜索中查有关transurethral surgery的内容
在数字搜索中查有关transurethral surgery的内容
在概念知识元中查有关transurethral surgery的内容
在学术趋势中查有关transurethral surgery的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社